| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-Non-Repro-Sublethal - whole animal | body and organ growth versus controls | decreased @ 250, 1000 ng/g bw | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-Non-Repro-Sublethal - organ/system effects | incidence and severity of lesions in liver, spleen, bursa, thyroid versus controls | increased @ 50,250,1000 ng/g bw | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma enzyme activities indicative of hepatotoxicity versus controls | increased | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | hematocrit and hemoglobin values versus controls | no effect | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | hepatic monooxygenase activities versus controls | increased @ 50,250,1000 ng/g bw | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-EXP IND - accumulation | concentration in liver | in ng/g, wet wt: 156 (@ 50 ng/g), 380 (@ 250 ng/g), 1098 (@1000 ng/g) | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
| PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | relationship between hepatic PCB 126 concentrations and ratio of oxidized to reduced glutathione | positive correlation | 9-11/group | Nestling | 10 d | Toxicity Factor Datasets |
